Companies:
49,444
Total Market Cap:
134119014366645.60
Global Rank
#48905
Country Rank
#1280
Market Cap
110,266
Price
0.0001
Change (%)
0.00%
Volume
10,000
Synairgen plc's latest marketcap:
110,266
As of 06/13/2025, Synairgen plc's market capitalization has reached $110,266. According to our data, Synairgen plc is the 48905th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 110,266 |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -8,749,226 |
| Shares Out | 1.1 B |
| EPS (ttm) | -0.04 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/23/2025 |
Market Cap Chart
Data Updated: 06/13/2025
Synairgen plc's yearly market capitalization.
Synairgen plc has seen its market value drop from $399.83 M to $110,266 since 2020, representing a total decrease of 99.97% and an annual compound decline rate (CAGR) of 84.14%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/13/2025 | $110,266 | -98.09% | 48905 |
| 12/31/2024 | $5.78 M | -42.64% | 46561 |
| 12/29/2023 | $10.07 M | -59.68% | 44912 |
| 12/30/2022 | $24.97 M | -95.55% | 43219 |
| 12/31/2021 | $560.74 M | 40.24% | 41275 |
| 12/31/2020 | $399.83 M | 38054 |
Company Profile
About Synairgen plc
Synairgen plc is a biopharmaceutical company focused on discovering and developing innovative treatments for respiratory diseases.
Key Developments
- SNG001: An inhaled interferon beta therapy currently in pre-clinical trials for severe viral lung infections.
- Inhaled Interferon Beta (IFN-ß): A naturally occurring protein that modulates the immune system to combat viruses, including coronaviruses.
Company Background
Founded in 2004, Synairgen plc is headquartered in Southampton, United Kingdom.
Frequently Asked Questions
-
What is Synairgen plc's (OTC-SYGGF) current market cap?As of 06/13/2025, Synairgen plc (including the parent company, if applicable) has an estimated market capitalization of $110,266 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Synairgen plc (OTC-SYGGF) rank globally by market cap?Synairgen plc global market capitalization ranking is approximately 48905 as of 06/13/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.